Publisher Correction: Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs

Matthew R Golder; Jenny Liu; Jannik N Andersen; Michail V Shipitsin; Farrukh Vohidov; Hung V-T Nguyen; Deborah C Ehrlich; Sung Jin Huh; Bhavatarini Vangamudi; Kyriakos D Economides; Allison M Neenan; James C Ackley; Joelle Baddour; Sattanathan Paramasivan; Samantha W Brady; Eric J Held; Lawrence A Reiter; Jennifer K Saucier-Sawyer; Paul W Kopesky; Donald E Chickering; Peter Blume-Jensen; Jeremiah A Johnson

doi:10.1038/s41551-018-0299-6

Publisher Correction: Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs

Nat Biomed Eng. 2018 Sep;2(9):707. doi: 10.1038/s41551-018-0299-6.

Authors

Matthew R Golder¹, Jenny Liu^{1

2}, Jannik N Andersen², Michail V Shipitsin², Farrukh Vohidov¹, Hung V-T Nguyen¹, Deborah C Ehrlich¹, Sung Jin Huh², Bhavatarini Vangamudi², Kyriakos D Economides², Allison M Neenan², James C Ackley², Joelle Baddour², Sattanathan Paramasivan², Samantha W Brady², Eric J Held², Lawrence A Reiter², Jennifer K Saucier-Sawyer², Paul W Kopesky², Donald E Chickering², Peter Blume-Jensen^{3

4}, Jeremiah A Johnson⁵

Affiliations

¹ Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.
² XTuit Pharmaceuticals, Waltham, MA, USA.
³ XTuit Pharmaceuticals, Waltham, MA, USA. pblumejensen@xtuit.com.
⁴ Acrivon Therapeutics, Lab Central, Cambridge, MA, USA. pblumejensen@xtuit.com.
⁵ Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA. jaj2109@mit.edu.

PMID: 31015683
DOI: 10.1038/s41551-018-0299-6

Abstract

In the version of this Article originally published, the author Peter Blume-Jensen was not denoted as a corresponding author; this has now been amended and the author's email address has been added. The 'Correspondence and requests for materials' statement was similarly affected and has now been updated with the author's initials 'P.B-J.'

Publication types

Published Erratum